LRCX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LRCX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Lam Research's change in receivables for the quarter that ended in Dec. 2023 was $0 Mil. It means Lam Research's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .
Lam Research's change in receivables for the fiscal year that ended in Jun. 2023 was $1,452 Mil. It means Lam Research's Accounts Receivable declined by $1,452 Mil from Jun. 2022 to Jun. 2023 .
Lam Research's Accounts Receivable for the quarter that ended in Dec. 2023 was $2,707 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lam Research's Days Sales Outstanding for the three months ended in Dec. 2023 was 65.74.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lam Research's liquidation value for the three months ended in Dec. 2023 was $-678 Mil.
The historical data trend for Lam Research's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lam Research Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | 732.14 | -641.83 | -928.93 | -1,287.68 | 1,452.26 |
Lam Research Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Change In Receivables | Get a 7-Day Free Trial | - | - | - | - | - |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lam Research (NAS:LRCX) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Lam Research's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 2707.458 | / | 3758.259 | * | 91 |
= | 65.74 |
2. In Ben Graham's calculation of liquidation value, Lam Research's accounts receivable are only considered to be worth 75% of book value:
Lam Research's liquidation value for the quarter that ended in Dec. 2023 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 5638.009 | - | 10561.374 | + | 0.75 * 2707.458 | + | 0.5 * 4429.906 |
= | -678 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Lam Research's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Timothy Archer | officer: Chief Operating Officer | 4650 CUSHING PARKWAY, FREMONT CA 94538 |
Ava Hahn | officer: Chief Legal Officer & SVP | 4650 CUSHING PARKWAY, C/O LAM RESEARCH, FREMONT CA 94538 |
Abhijit Y Talwalkar | director | ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088 |
Christina Corrreia | officer: CVP , Chief Accounting Officer | 4650 CUSHING PKWY, FREMONT CA 94538 |
Patrick J Lord | officer: Group Vice President | C/O LAM RESEARCH CORP, 4650 CUSHING PARKWAY, FREMONT CA 94538 |
John M. Dineen | director | MERRIMACK PHARMACEUTICALS, INC., ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE MA 02139 |
Douglas R Bettinger | officer: EVP, Chief Financial Officer | C/O LAM RESEARCH CORPORATION, 4650 CUSHING PARKWAY, FREMONT CA 94538 |
Vahid Vahedi | officer: Group Vice President | LAM RESEARCH CORPORATION, 4650 CUSHING PARKWAY, FREMONT CA 94538 |
Neil J Fernandes | officer: Senior Vice President | 4650 CUSHING PKWY, FREMONT CA 94538 |
Ho Kyu Kang | director | 4650 CUSHING PKWY, FREMONT CA 94538 |
Richard A Gottscho | officer: Executive Vice President | 4650 CUSHING PARKWAY, FREMONT CA 94538 |
Sohail U Ahmed | director | 4650 CUSHING PARKWAY, FREMONT CA 94538 |
Scott Gerald Meikle | officer: Senior Vice President | 1007 N. 17TH STREET, BOISE ID 83702 |
Catherine P Lego | director | C/O GUIDEWIRE SOFTWARE, INC., 970 PARK PL, SUITE 200, SAN MATEO CA 94403 |
Seshasayee Varadarajan | officer: Group Vice President | LAM RESEARCH CORPORATION, 4650 CUSHING PARKWAY, FREMONT CA 94538 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.